EGFR-TKI resistance and epigenetic alterations in lung cancer treatment
Project/Area Number |
16H06988
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Respiratory surgery
|
Research Institution | Okayama University |
Principal Investigator |
|
Research Collaborator |
SATO Hiroki
TOMIDA Shuta
TOYOOKA Shinichi
|
Project Period (FY) |
2016-08-26 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 非小細胞肺癌 / EGFR / 薬剤耐性 / マイクロRNA / 癌 / トランスレーショナルリサーチ / 薬剤反応性 |
Outline of Final Research Achievements |
Patients with EGFR-activating mutations who initially respond to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) eventually acquire drug resistance, which is a critical problem in the treatment of patients with advanced lung cancer. In this study, we clarified the relation between epigenetic alteration and EGFR-TKI resistance. We found that the micro RNA-200 and LIN28B axis, known as an oncogenic stem-cell factor, plays an important role in the cell viability of acquired EGFR-TKI resistance cells.
|
Report
(2 results)
Research Products
(2 results)
-
[Journal Article] Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.2017
Author(s)
Sato H, Shien K, Tomida S, Okayasu K, Suzawa K, Hashida S, Torigoe H, Watanabe M, Yamamoto H, Soh J, Asano H, Tsukuda K, Miyoshi S, Toyooka S.
-
Journal Title
Sci Rep.
Volume: 7
Issue: 1
Pages: 40847-40847
DOI
Related Report
Peer Reviewed / Open Access
-
[Presentation] Targeting miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features2016
Author(s)
Kazuhiko Shien, Hiroki Sato, Ken Suzawa, Shuta Tomida, Shinsuke Hashida, Hiromasa Yamamoto, Junichi Soh, Hidejiro Torigoe, Kei Namba, Mototsugu Watanabe, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
Organizer
IASCL World Congress on Lung Cancer 2016
Place of Presentation
Vienna, Austria
Year and Date
2016-12-04
Related Report
Int'l Joint Research